SAN FRANCISCO (MarketWatch) Shares of WD-40 Co. slipped in the extended session Wednesday on an earnings miss.

WD-40 WDFC, -3.33% shares fell 5.2% to $81 on light volume after the companys fiscal first-quarter results fell short of Wall Street expectations.

Shares of NephroGenex Inc. NRX, +5.21% rose 19% to $10.99 on moderate volume after the clinical-stage drug company said late-stage studies on its diabetic nephropathy treatment Pyridorin would be able to support a marketing application in Europe. The company also disclosed that RHO Capital had taken an 11.9% stake in the company.

Bind Therapeutics Inc. BIND, +58.83% shares jumped 26% to $6.50 on moderate volume. The nanomedicine platform company said it expects one of its collaboration partners will file a drug application with the FDA by mid-2015 using their Accurin drug delivery particles.

Mistras Group Inc. MG, +12.53% shares rose 13% to $20.63 on light volume after the company reported fiscal second-quarter earnings of 33 cents a share on revenue of $206.9 million. Analysts had estimated 26 cents a share on revenue of $186.2 million.

Alexion Pharmaceuticals Inc. ALXN, -2.21% shares fell 4.8% to $179 in late trading after the company said a phase 2 clinical trial of eculizumab -- a drug to help prevent rejection of kidney transplants -- failed to meet its primary composite endpoint.

Insulet Corp. PODD, -8.16% shares fell 7.9% to $41 on moderate volume after the insulin pump company said it expects fourth-quarter revenue of $71 million to $73 million, down from a previous estimate of $76 million to $81 million, because of a delay in product shipments. Analysts had expected $79.6 million.

Zumiez Inc. ZUMZ, -0.65% shares rose 2.7% to $41.35 on light volume after the specialty retailer raised its guidance for the fourth quarter.

These were the stocks making notable moves during the regular session Wednesday:

Keurig Green Mountain Inc. GMCR, +2.30% signed a deal with Dr Pepper Snapple Group Inc. DPS, +1.67% to sell capsules that make its sodas in Keurigs planned cold-drink machine.

See the rest here:
Movers & Shakers: WD-40 shares slip as results fall below Street view